Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

66.7%

4 terminated/withdrawn out of 6 trials

Success Rate

20.0%

-66.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting4 withdrawn

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06642142Recruiting

Onset of Sensory Block After Thoracic ESP Block

Role: lead

NCT05936541Not ApplicableCompleted

Modulation of Bifidocentric Dysbiosis Through Bifidobacterium Bifidum PRL2010 Supplementation in Caesarian-born Infants

Role: collaborator

NCT01411475Withdrawn

Prognostic Assessment of Different Pattern of Bifurcation Restenosis

Role: lead

NCT01009996Withdrawn

Efficacy Study of Kissing Drug-Eluting Balloons in Coronary Bifurcation Lesions

Role: lead

NCT01411462Withdrawn

VIBE-assisted DEB Registry

Role: lead

NCT01060306Withdrawn

Optical Coherence Tomography Evaluation of a Biodegradable Polymer-based Drug-eluting Stent

Role: lead

All 6 trials loaded